You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Raymond James Financial, Inc. (RJF) - free report >>
Spero Therapeutics, Inc. (SPRO) - free report >>
Applied Digital Corporation (APLD) - free report >>
Image: Shutterstock
New Strong Buy Stocks for November 15th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Federated Hermes, Inc. (FHI - Free Report) : This global asset manager has seen the Zacks Consensus Estimate for its current year earnings increasing 12.5% over the last 60 days.
Federated Hermes, Inc. Price and Consensus
Federated Hermes, Inc. price-consensus-chart | Federated Hermes, Inc. Quote
Raymond James Financial, Inc. (RJF - Free Report) : This diversified financial services company has seen the Zacks Consensus Estimate for its current year earnings increasing 5.8% over the last 60 days.
Raymond James Financial, Inc. Price and Consensus
Raymond James Financial, Inc. price-consensus-chart | Raymond James Financial, Inc. Quote
AST SpaceMobile, Inc. (ASTS - Free Report) : This space-based cellular broadband network provider has seen the Zacks Consensus Estimate for its current year earnings increasing 5.8% over the last 60 days.
AST SpaceMobile, Inc. Price and Consensus
AST SpaceMobile, Inc. price-consensus-chart | AST SpaceMobile, Inc. Quote
Applied Digital Corporation (APLD - Free Report) : This digital infrastructure and cloud solutions provider has seen the Zacks Consensus Estimate for its current year earnings increasing 64.3% over the last 60 days.
Applied Digital Corporation Price and Consensus
Applied Digital Corporation price-consensus-chart | Applied Digital Corporation Quote
Spero Therapeutics, Inc.(SPRO - Free Report) : This clinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 13.2% over the last 60 days.
Spero Therapeutics, Inc. Price and Consensus
Spero Therapeutics, Inc. price-consensus-chart | Spero Therapeutics, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.